Objective To compare the effectiveness of outpatient medical abortion with mifepristone 200
mg and two misoprostol 800 mcg doses at 64–70 and 71–77 days of gestation. Study design …

Clinical Update on Uses for Mifepristone in Obstetrics and G... : Obstetrical & Gynecological
Survey Clinical Update on Uses for Mifepristone in Obstetrics and Gynecology : Obstetrical & …

Mifepristone is an anti‐progestational drug that is the first component of the standard
medical abortion regimen. For women who take mifepristone and then do not take …

In 2017, mifepristone and misoprostol became available for early pregnancy termination as
the combination pack Mifegymiso® in Ottawa, Ontario, Canada. We conducted 40 semi …

Importance In the US, access to medication abortion using history-based (no-test) eligibility
assessment, including through telehealth and mailing of mifepristone, has grown rapidly …

Objective To determine the proportion of complete abortion without surgical intervention for
patients who chose medication abortion with vaginal compared to buccal misoprostol …

Objectives: Identify appropriate indications for mifepristone use in elective abortion
procedures and other medical conditions. Screen patients to assess their eligibility for …

Mifepristone (RU-486), a synthetic steroid with potent antiprogestogen and anti-
glucocorticoid properties, has been widely used in clinical practice. Its effect on the …

The clinical use of mifepristone for medical abortions has been established in 1987 in
France and since 2000 in the United States. Mifepristone has a limited medical period that …

The increasing literature on early pregnancy mifepristone antagonisation by progesterone is
encouraging, as we seek to better serve women in this difficult situation. Nevertheless, there …